PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
09-Dec-2020 Merck Launches Scepter™ 3.0 Instrument for Wireless Cell Counting Precision Merck
09-Dec-2020 Orgenesis signs joint venture with Cure Therapeutics to advance point-of-care development and commercialization of cell and gene therapies Orgenesis Inc
09-Dec-2020 Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer Evelo Biosciences, Inc
09-Dec-2020 RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer Exact Sciences Corp
09-Dec-2020 Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer Evelo Biosciences, Inc
09-Dec-2020 Evelo Biosciences Reports Positive Topline Clinical Data in Phase 1b Trial of EDP1815 in Atopic Dermatitis Evelo Biosciences, Inc
09-Dec-2020 Clasado announces clinician-led gut health digital event for February 2021 Clasado
09-Dec-2020 GENTRONIX EXPANDS SERVICES TO MEET GROWING GLOBAL DEMAND Contract Research Organisation (CRO)
09-Dec-2020 PureTech Founded Entity Follica Announces Pilot Study for Female Pattern Hair Loss Published in International Journal of Women’s Dermatology PureTech Health plc
09-Dec-2020 Evelo Biosciences Reports Positive Topline Clinical Data in Phase 1b Trial of EDP1815 in Atopic Dermatitis Evelo Biosciences, Inc.
09-Dec-2020 ISPE Foundation Partners with Gilead Sciences on Internship Program to Diversify the Pharma Industry’s Workforce ISPE Foundation
09-Dec-2020 AlzeCure receives approval to start clinical Phase Ib trial with ACD440 in neuropathic pain AlzeCure Pharma AB
09-Dec-2020 YESCARTA® (AXICABTAGENE CILOLEUCEL) IS FIRST CAR T CELL THERAPY TO DEMONSTRATE HIGH RESPONSE RATES AND DURABLE CLINICAL BENEFIT IN A PIVOTAL INDOLENT NON-HODGKIN LYMPHOMA STUDY Kite, a Gilead Company
09-Dec-2020 I-Mab Accelerates Clinical Development of Anti-CD47 Monoclonal Antibody Lemzoparlimab in the US and China I-Mab
09-Dec-2020 Creating a win:win dialogue between NHS and pharma industry to support the spread and scale of innovation BOB.health
09-Dec-2020 Sanofi pioneers sustainable finance in the pharmaceutical industry with the signing of its two first sustainability-linked revolving credit facilities Sanofi
09-Dec-2020 Amryt Group Receives Marketing Authorisation Approval for Lojuxta® in Brazil Amryt
09-Dec-2020 CD Bioparticles Introduces Innovative Fluorescent Polymers to Support Research CD Bioparticles
08-Dec-2020 PFIZER REPORTS POSITIVE CLINICAL DATA FOR BCMA-CD3 BISPECIFIC ANTIBODY (PF-06863135) IN MULTIPLE MYELOMA Pfizer
08-Dec-2020 Roche presents new data from its bispecific antibody portfolio across a range of blood cancers Roche